Does MOXONIDINE Cause Maternal exposure timing unspecified? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Maternal exposure timing unspecified have been filed in association with MOXONIDINE. This represents 2.1% of all adverse event reports for MOXONIDINE.
16
Reports of Maternal exposure timing unspecified with MOXONIDINE
2.1%
of all MOXONIDINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From MOXONIDINE?
Of the 16 reports.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOXONIDINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does MOXONIDINE Cause?
Hypotension (97)
Renal impairment (86)
Dizziness (85)
Hyperkalaemia (76)
Abdominal pain (69)
Acute kidney injury (67)
Bradycardia (58)
Drug ineffective (55)
Hypertension (55)
Nausea (50)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which MOXONIDINE Alternatives Have Lower Maternal exposure timing unspecified Risk?
MOXONIDINE vs MS CONTIN
MOXONIDINE vs MULTAQ
MOXONIDINE vs MULTIHANCE
MOXONIDINE vs MUPIROCIN
MOXONIDINE vs MUPIROCIN\MUPIROCIN